Allocated but not treated: the silent 16% – Authors' reply
Main Authors: | Horby, P, Staplin, N, Emberson, J, Haynes, R, Landray, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2022
|
Similar Items
-
The authors reply
by: Chapman, D, et al.
Published: (2023) -
Methylprednisolone, intravenous immunoglobulin, tocilizimab or anakinra for children with Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS CoV-2 (PIMS-TS, MIS-C) – report from a randomised, controlled, open-label, platform trial
by: Haynes, R, et al.
Published: (2023) -
Evidence for the prevention and treatment of stroke in dialysis patients
by: Herrington, W, et al.
Published: (2014) -
Cholesterol, statins, and mortality - Authors' reply
by: Lewington, S, et al.
Published: (2008) -
Hydroxychloroquine in hospitalized patients with Covid-19. Reply
by: Horby, P, et al.
Published: (2021)